Amebiasis Vaccine
Amebiasis vaccine progress is reviewed
Published in Vaccine Weekly, March 29th, 2006
"The persistence of amebiasis as a global health problem, despite the availability of effective treatment, has led to the search for vaccines to prevent this deadly disease. Recent clinical studies suggest that mucosal immunity could provide some protection against recurrent intestinal infection with E. histolytica, but there is contradictory evidence about protective immunity after amebic liver abscess. Progress in vaccine development has been facilitated by new animal models that allow better testing of potential vaccine candidates and by the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-03-29)
More Articles from Vaccine Weekly
- Plague Vaccine
Plague is protected against by Yersinia pestis antigens expressed in plants - Rotavirus Vaccine
Ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates Th1 response - Schistosomiasis Vaccine
Schistosoma japonicum paramyosin fragments were effective in mice - Schistosomiasis Vaccine
Genes expressed in lung schistosomulum of Schistosoma mansoni are identified - Smallpox Vaccine
Monkeypox virus infection is more effectively treated with antivirals than with smallpox vaccine - Anthrax Vaccines
Findings advance knowledge in anthrax vaccines research - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
